InvestorsHub Logo
Followers 17
Posts 1550
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Friday, 05/23/2025 9:42:21 AM

Friday, May 23, 2025 9:42:21 AM

Post# of 624
$1.68 The short/intermediate term issue is that there doesn't seem to be any catalyst to drive this stock forward until the "partners" actually settle on a dosage, expand the Phase 1/2 trial to cover enough people to make it meaningful, and somehow decide that enough is enough and apply for Phase III. Does anyone want to guess on a timeframe?